NCT04651179View on ClinicalTrials.gov

Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

June 6, 2021

Study Completion Date

November 23, 2021

Conditions
Osteosarcoma RecurrentOsteosarcoma Metastatic
Interventions
OTHER

observation

not applicable, observational study

Trial Locations (8)

10060

Fondazione del Piemonte per l' Oncologia IRCCS Candiolo, Candiolo

10126

AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita, Turin

20133

Istituto Nazionale Tumori, Milan

IRCCS Istituto Nazionale dei Tumori, Milan

40136

Istituto Ortopedico Rizzoli, Bologna

50134

AOUC Azienda Ospedaliero-Universitaria Careggi, Florence

Unknown

Azienda Ospedaliero Universitaria pisana, Pisa

00144

IRCCS Istituti Fisioterapici Ospitalieri, Rome

All Listed Sponsors
lead

Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

OTHER

NCT04651179 - Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma | Biotech Hunter | Biotech Hunter